Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12622000747729
Ethics application status
Approved
Date submitted
17/05/2022
Date registered
25/05/2022
Date last updated
23/02/2024
Date data sharing statement initially provided
25/05/2022
Type of registration
Prospectively registered
Titles & IDs
Public title
Digitising colonoscopy care pathways and enhancing bowel preparation quality with patient reported measures (DIGICLEAN).
Query!
Scientific title
A multicentre, colonoscopist-blinded, randomised controlled trial to determine the efficacy of dynamic multimedia bowel preparation instructions versus standard instructions as control on adenoma detection and patient reported measures in adults aged 45 years and older indicated for a colonoscopy.
Query!
Secondary ID [1]
307118
0
None
Query!
Universal Trial Number (UTN)
U1111-1278-2201
Query!
Trial acronym
DIGICLEAN (DIGItising CoLonoscopy care pathways to Enhance bowel preparation And polyp detectioN)
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
colorectal cancer
326283
0
Query!
Condition category
Condition code
Cancer
323597
323597
0
0
Query!
Bowel - Back passage (rectum) or large bowel (colon)
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Participants in the interventional arm of the study will receive their bowel preparation instructions delivered via scheduled SMS, web-based smartphone application, email, and videos. All enrolled participants must possess a smartphone device. The interventional arm will occur in parallel design with the control arm. Depending on whether participants have a history of constipation, bloating, or diverticular disease as assessed by the faecal occult blood test (FOBT) nurse or the gastroenterologist at the initial phone call, participants will be stratified into one of two groups depending on their indicated bowel preparation regimens.
Participants will be either given Standard Bowel Preparation instructions with PLENVU [macrogol 3350, sodium ascorbate, sodium sulfate anhydrous, ascorbic acid, sodium chloride, potassium chloride; polyethylene glycol containing ascorbic acid (PEG-ASC)], or Enhanced Bowel Preparation [PLENVU plus daily Movicol (sodium chloride, potassium chloride, bicarbonate, macrogol 3350) and Senokot (sennoside)]. Additional aperients, such as Movicol and Senokot, will be encouraged in the interventional arm through dynamic multimedia instructions if indicated. Participants will be asked to take PLENVU over a two-day split dosing schedule with the first 500 mL dose of PLENVU (including additional 500 mL of clear fluid) taken in the evening before the clinical procedure (at 6 pm) and the second 500 mL dose (including additional 500 mL of clear fluid) in the early morning of the day of the clinical procedure (at 5 am for morning procedure or 8 am for afternoon procedures). Participants in the Enhanced Bowel Preparation group will also take 1 sachet of Movicol and 2 Senokot tablets daily at 0800 in the week leading up to the colonoscopy.
In the week leading up to the colonoscopy, depending on the bowel preparation group, regular SMS will be sent to the participant one to three times daily to remind participants regarding appropriate dietary and bowel preparation instructions (at 0800, 1700 and 2000). Scheduled SMS and messaging will also occur on the day prior to colonoscopy occurring at indicated times to consume bowel preparation. Daily assessment of dietary adherence and constipation, which involves completing a survey lasting for two to five minutes, will occur via the web-based smartphone application and depending on patient reported responses, dietary advice or alterations in bowel preparation will be given. The message delivery system will be monitored via a web interface by the FOBT nurse or the study nurse. A video explaining the procedure and the bowel preparation course will be sent to the participant via SMS and email at the time of enrolment and at 7 days before the colonoscopy, which can be re-accessed through a hyperlink. Participants will be asked to self-report their stool consistency and stool colour via the smartphone app after completion of their bowel preparation before the colonoscopy, and if unsatisfactory, may be advised to request a Fleet enema (sodium biphosphate and sodium phosphate) at time of arrival to the hospital. A Fleet enema is a laxative given via the rectum which causes bowel movements in around give minutes.
After the colonoscopy, patient reported measures will be assessed. Additionally, depending on the site of the study, some participants will undergo their pre-anaesthetic assessment using the web-based application which will occur once at the time of enrolment.
Query!
Intervention code [1]
323578
0
Early detection / Screening
Query!
Intervention code [2]
323630
0
Diagnosis / Prognosis
Query!
Comparator / control treatment
Participants in the control arm of the study will receive their bowel preparation instructions delivered via routine standard means, such as written, verbal, emailed or posted instructions. Depending on whether participants have a history of constipation, bloating, or diverticular disease as assessed by the FOBT nurse or the gastroenterologist at the initial phone call, participants will be stratified into one of two groups depending on their indicated bowel preparation regimens. Participants will be either given instructions for Standard Bowel Preparation with PLENVU [macrogol 3350, sodium ascorbate, sodium sulfate anhydrous, ascorbic acid, sodium chloride, potassium chloride; polyethylene glycol containing ascorbic acid (PEG-ASC)], or Enhanced Bowel Preparation [PLENVU plus regular Movicol (sodium chloride, potassium chloride, bicarbonate, macrogol 3350) and Senokot (sennosides)]. Additional aperients may be encouraged in the control arm but this will be presented as paper-based/written instructions. The bowel preparation regimens are the same as the interventional groups. Participants in the control arm will be given the same instructions in paper-based/emailed form (including instructions for additional aperients), but not through dynamic multimedia messaging and participants will not be routinely assessed for constipation leading up to their procedure. Participants will be advised via written means to request a Fleet enema (sodium biphosphate and sodium phosphate) at time of arrival to the hospital if their stool consistency or stool colour is unsatisfactory. A Fleet enema is a laxative given via the rectum which causes bowel movements in around give minutes. After the colonoscopy, patient reported measures and self-reported adherence will be assessed. Adherence to diet, constipation, and bowel preparation routine will not be assessed prior to colonoscopy via digital means.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
331377
0
Comparison of the adenoma detection rate based on histopathology assessment of biopsy samples collected at the time of colonoscopy in patients randomised to receive dynamic multimedia bowel preparation instructions versus those that receive verbal and/or written bowel preparation instructions.
Query!
Assessment method [1]
331377
0
Query!
Timepoint [1]
331377
0
At the time of colonoscopy assessment.
Query!
Primary outcome [2]
331379
0
Compare the patient reported measures using the validated colonoscopy-specific Newcastle ENDOPREM Questionnaire on the day after colonoscopy between patients randomised to receive dynamic multimedia bowel preparation instructions versus those that receive standard verbal and/or written bowel preparation instructions.
Query!
Assessment method [2]
331379
0
Query!
Timepoint [2]
331379
0
One day after colonoscopy assessment.
Query!
Secondary outcome [1]
409661
0
Compare the Boston Bowel Preparation Score at the time of colonoscopy in patients randomised to receive dynamic multimedia bowel preparation instructions versus those that receive verbal and/or written bowel preparation instructions.
Query!
Assessment method [1]
409661
0
Query!
Timepoint [1]
409661
0
At the time of colonoscopy assessment.
Query!
Secondary outcome [2]
409662
0
Compare the caecal intubation success rate at the time of colonoscopy on review of the procedural report between patients randomised to receive dynamic multimedia bowel preparation instructions versus those that receive standard verbal and/or written bowel preparation instructions.
Query!
Assessment method [2]
409662
0
Query!
Timepoint [2]
409662
0
At the time of colonoscopy assessment.
Query!
Secondary outcome [3]
409663
0
Compare the mean procedural time duration measured in minutes from the time of colonoscope insertion through to removal from the anal canal on review of the procedural report between patients randomised to receive dynamic multimedia bowel preparation instructions versus those that receive standard verbal and/or written bowel preparation instructions.
Query!
Assessment method [3]
409663
0
Query!
Timepoint [3]
409663
0
At the time of colonoscopy assessment.
Query!
Secondary outcome [4]
409664
0
Compare the cancellation and non-presentation rate related to patient factors on review of medical records between patients randomised to receive dynamic multimedia bowel preparation instructions versus those that receive standard verbal and/or written bowel preparation instructions.
Query!
Assessment method [4]
409664
0
Query!
Timepoint [4]
409664
0
At the time of colonoscopy assessment.
Query!
Eligibility
Key inclusion criteria
1. Indicated for colonoscopy as an outpatient with a positive faecal occult blood test, rectal bleeding, or iron deficiency anaemia
2. Aged 45 years and above
3. Have a smartphone device which can support web browsing and use the web-based application
4. Be able to independently give informed consent by verbal means
5. Possess a working email address for the purposes of consenting and information sharing
Query!
Minimum age
45
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
1. Non-English-speaking backgrounds
2. Inpatient at any hospital
3. Scheduled colonoscopy date changed or delayed due to provider factors affecting the normal care sequence
4. Colonoscopy within the last 5 years.
5. Previous bowel resection or stoma
6. Glucose-6-phosphate dehydrogenase deficiency (due to the presence of ascorbic acid in PEG-ASC)
7. New York Heart Association heart failure classes III or IV
8. Chronic kidney disease stages 4 and 5 (eGFR < 30 mL/min/1.73m2)
9. Not indicated or contraindicated for a colonoscopy
10. Contraindication to standard bowel preparation regimens
11. Hypersensitivity to any ingredient in PLENVU
12. Cognitive disorder which would normally preclude from independent standard bowel preparation
13. Inflammatory bowel disease
14. Known polyp or diagnosis of colorectal cancer
Query!
Study design
Purpose of the study
Diagnosis
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Sequentially numbered, opaque, sealed envelope
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Permuted block randomisation. Participants will be stratified by their indicated bowel preparation regimen: PLENVU only or Enhanced Bowel Preparation in patients with a history of constipation, diverticular disease, or bloating.
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people assessing the outcomes
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Power calculations were based on a previous randomised controlled trial by Walter, Frank et al., which compared the quality of bowel preparation and adenoma detection rates with 2 L polyethylene glycol (PEG) plus ascorbic acid, in patients who received a smartphone application versus patients who received written materials that had the same contents.
This study is of independent cases and controls with 1 control per case. Prior data from Walter, Frank et al. indicate that the adenoma detection rate among controls is 0.27. If the true adenoma detection rate for experimental subjects is 0.35, the study will need 524 experimental subjects and 524 control subjects to be able to reject the null hypothesis that the adenoma detection rates for experimental and control subjects are equal with probability (power) 0.80. The Type I error probability associated with this test of this null hypothesis is 0.05. An uncorrected chi-squared statistic to evaluate this null hypothesis will be used.
Given the multiple stages of data collection in the interventional arm (at 1 week prior, -3 days prior, -1 day prior and morning of procedure) which may be burdensome as well as some patients who may not show up for the procedure, a drop-out rate of 10% will be anticipated. The adjusted sample size reflecting this is 1294. To account for these factors, we will aim to enrol 647 participants in both the interventional and control arms.
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
31/03/2023
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
30/09/2024
Query!
Actual
Query!
Date of last data collection
Anticipated
30/10/2024
Query!
Actual
Query!
Sample size
Target
1294
Query!
Accrual to date
0
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
NSW
Query!
Recruitment hospital [1]
22369
0
Blacktown Hospital - Blacktown
Query!
Recruitment hospital [2]
22370
0
Mount Druitt Hospital - Mount Druitt
Query!
Recruitment hospital [3]
22371
0
Concord Repatriation Hospital - Concord
Query!
Recruitment hospital [4]
22372
0
Campbelltown Hospital - Campbelltown
Query!
Recruitment postcode(s) [1]
37532
0
2148 - Blacktown
Query!
Recruitment postcode(s) [2]
37533
0
2770 - Mount Druitt
Query!
Recruitment postcode(s) [3]
37534
0
2139 - Concord
Query!
Recruitment postcode(s) [4]
37535
0
2560 - Campbelltown
Query!
Funding & Sponsors
Funding source category [1]
311426
0
Hospital
Query!
Name [1]
311426
0
Western Sydney Local Health District, Westmead Hospital, Research Education Network
Query!
Address [1]
311426
0
WSLHD Research and Education Network,
Westmead Hospital,
Hawkesbury Road,
Westmead NSW 2145
Query!
Country [1]
311426
0
Australia
Query!
Funding source category [2]
313278
0
Commercial sector/Industry
Query!
Name [2]
313278
0
Norgine Pty Limited
Query!
Address [2]
313278
0
Suite 3.01 Building A
20 Rodborough Road
Frenchs Forest NSW 2086 Australia
Query!
Country [2]
313278
0
Australia
Query!
Primary sponsor type
Individual
Query!
Name
Dr Viraj Kariyawasam
Query!
Address
Blacktown Hospital
18 Blacktown Road
Blacktown NSW 2148
Query!
Country
Australia
Query!
Secondary sponsor category [1]
312820
0
Individual
Query!
Name [1]
312820
0
Dr Michael Au
Query!
Address [1]
312820
0
Blacktown Hospital
18 Blacktown Road
Blacktown NSW 2148
Query!
Country [1]
312820
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
310903
0
Western Sydney Local Health District Human Research Ethics Committee
Query!
Ethics committee address [1]
310903
0
WSLHD Human Research Ethics Committee
Research Office
Level 2
REN Building
Westmead Hospital
Cnr Hawkesbury & Darcy Roads
Westmead NSW 2145
Query!
Ethics committee country [1]
310903
0
Australia
Query!
Date submitted for ethics approval [1]
310903
0
15/01/2022
Query!
Approval date [1]
310903
0
21/03/2022
Query!
Ethics approval number [1]
310903
0
2022/ETH00059
Query!
Summary
Brief summary
This study aims to determine whether delivery of bowel preparation instructions for a colonoscopy through dynamic multimedia instructions (scheduled SMS, smartphone application, video instructions, and email) has an impact on the quality of bowel preparation, diagnosis rate and colonoscopy procedure times compared to instructions that are given verbally, in hard copy or via email only.
Who is it for?
You may be eligible for this study if you are aged 45 years or older, you have been scheduled to attend a colonoscopy as an outpatient to screen for potential colorectal cancer and you have access to a smartphone.
Study details
All participants will be instructed to take either a ‘Standard Bowel Preparation’ or 'Enhanced Bowel Preparation' depending upon their bowel habits. The only difference between the groups is how the instructions for bowel preparation will be delivered. All participants who choose to enrol in this study will be randomly allocated by chance (similar to flipping a coin) to receive their bowel preparation instructions either by SMS, video and through a smartphone app, or to receive their instructions verbally, in paper/hard copy format or email only. Participants who are allocated to the SMS/smartphone group will receive 1-3 daily reminders throughout the week prior to their colonoscopy and will be asked to enter details about their preparation each day for 1 week prior to the colonoscopy. This should only take 2-5 minutes per day. Participants who are allocated to the paper/email group will receive a copy of the instructions once only and will not receive any reminders prior to their colonoscopy. All participants will be asked to complete a series of questionnaires after their colonoscopy, this is anticipated to take 10 minutes.
It is hoped this research will demonstrate whether a more interactive delivery of instructions for colonoscopy has any impact upon the ability to diagnose bowel cancer and the ease of the procedure itself. If this method is successful, it may be implemented on a larger scale which could improve the diagnosis and treatment of bowel cancers.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
119290
0
Dr Viraj Kariyawasam
Query!
Address
119290
0
Department of Gastroenterology and Hepatology
Blacktown Hospital
18 Blacktown Road
Blacktown NSW 2148
Query!
Country
119290
0
Australia
Query!
Phone
119290
0
+61 493 267 442
Query!
Fax
119290
0
Query!
Email
119290
0
[email protected]
Query!
Contact person for public queries
Name
119291
0
Dr Michael Au
Query!
Address
119291
0
Department of Gastroenterology and Hepatology
Blacktown Hospital
18 Blacktown Road
Blacktown NSW 2148
Query!
Country
119291
0
Australia
Query!
Phone
119291
0
+61 494 042 862
Query!
Fax
119291
0
Query!
Email
119291
0
[email protected]
Query!
Contact person for scientific queries
Name
119292
0
Dr Michael Au
Query!
Address
119292
0
Department of Gastroenterology and Hepatology
Blacktown Hospital
18 Blacktown Road
Blacktown NSW 2148
Query!
Country
119292
0
Australia
Query!
Phone
119292
0
+61 494 042 862
Query!
Fax
119292
0
Query!
Email
119292
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Not approved by Human Research Ethics Committee at the present time.
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Doc. No.
Type
Citation
Link
Email
Other Details
Attachment
16077
Ethical approval
[email protected]
16078
Informed consent form
https://bmjopen.bmj.com/content/13/7/e073843
[email protected]
16079
Study protocol
https://bmjopen.bmj.com/content/13/7/e073843
[email protected]
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF